Literature DB >> 2439104

The structure of T-cell epitopes.

A M Livingstone, C G Fathman.   

Abstract

We have reviewed here studies using synthetic peptides to analyze some of the properties of T-cell epitopes. Several general conclusions can be drawn. First, T-cell epitopes can usually be defined by linear sequences of about seven amino acids. However, the observation that increasing peptide length often results in increased antigenic potency has suggested that antigenicity may crucially depend upon the ability of peptides to adopt appropriate secondary structures. Two models for the prediction of T-cell epitopes on the basis of primary sequence data alone were discussed. Biophysical studies on the association of peptides with Ia molecules have shown that antigenic peptides bind directly to Ia; the evidence suggests that a binary association between Ia and peptide occurs in the absence of specific T-cells. Finally, a hypothesis to explain the observation that B-cells and T-cells generally recognize distinct epitopes on multideterminant antigens has been examined.

Mesh:

Substances:

Year:  1987        PMID: 2439104     DOI: 10.1146/annurev.iy.05.040187.002401

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  35 in total

1.  Allorecognition of DR1 by T cells from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptides.

Authors:  G Lombardi; S Sidhu; J R Batchelor; R I Lechler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

2.  Optimization of the delivery of heterologous proteins by the Salmonella enterica serovar Typhimurium type III secretion system for vaccine development.

Authors:  Li-Mei Chen; Gabriel Briones; Ruben O Donis; Jorge E Galán
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

3.  Mapping T-cell epitopes in group A streptococcal type 5 M protein.

Authors:  J H Robinson; M C Atherton; J A Goodacre; M Pinkney; H Weightman; M A Kehoe
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

4.  A first-order reaction controls the binding of antigenic peptides to major histocompatibility complex class II molecules.

Authors:  S N Witt; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

5.  Amphipathic segment of the nicotinic receptor alpha subunit contains epitopes recognized by T lymphocytes in myasthenia gravis.

Authors:  R Hohlfeld; K V Toyka; L L Miner; S L Walgrave; B M Conti-Tronconi
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

6.  T lymphocyte activation in systemic lupus erythematosus analysed by proliferative response to nucleoplasmic proteins on nitrocellulose immunoblots.

Authors:  B N Pham; L Prin; D Gosset; P Y Hatron; B Devulder; A Capron; J P Dessaint
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

7.  Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II.

Authors:  C L Ruegg; C R Monell; M Strand
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

8.  Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene.

Authors:  A Melms; S Chrestel; B C Schalke; H Wekerle; A Mauron; M Ballivet; T Barkas
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

9.  Myasthenia gravis. CD4+ T epitopes on the embryonic gamma subunit of human muscle acetylcholine receptor.

Authors:  M P Protti; A A Manfredi; X D Wu; L Moiola; M W Dalton; J F Howard; B M Conti-Tronconi
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

10.  A comparison of T cell responses to glycoprotein B (gB-1) of herpes simplex virus type 1 and its non-glycosylated precursor protein, pgB-1.

Authors:  C A O'Donnell; W L Chan
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.